John M. Evans, CEO: Beam Therapeutics BEAM Sell · Filed 04/06

Trade details

Type: Insider sale
Amount: $739,317.24
Shares · price: 30,078 sh · $24.58 a share
Held after: 1,047,205 sh
Stock: Beam Therapeutics BEAM
Person: John M. EvansCEO
Trade date: 26/04/01
Filed: 26/04/06
Days to filing: 5 days

Sold 2.8% of holdings

Share of holding sold: 2.8%

Beam Therapeutics trades, last 26 weeks

What else happened in Beam Therapeutics around then

Filed or reported within 30 days of the trade day · 03/02~05/01

John M. Evans's recent trades

John M. EvansCEO
Planned sale10b5-1 planBeam Therapeutics
Planned sale10b5-1 plan
Beam Therapeutics
BEAM
$857.7K
25,000 sh
$857.7K
Filed 06/30
Traded 06/30
John M. EvansCEO
Planned sale10b5-1 planBeam Therapeutics
Planned sale10b5-1 plan
Beam Therapeutics
BEAM
$887.4K
25,000 sh
$887.4K
Filed 06/29
Traded 06/29
John M. EvansCEO
Sell10b5-1 planBeam Therapeutics
Sell10b5-1 plan
Beam Therapeutics
BEAM
$569K
25,000 sh
$569K
Filed 04/01
Traded 03/31
John M. EvansCEO
Sell10b5-1 planBeam Therapeutics
Sell10b5-1 plan
Beam Therapeutics
BEAM
$559.3K
25,000 sh
$559.3K
Filed 04/01
Traded 03/30
John M. EvansCEO
Planned sale10b5-1 planBeam Therapeutics
Planned sale10b5-1 plan
Beam Therapeutics
BEAM
$1.5M
66,874 sh
$1.5M
Filed 03/31
Traded 04/02